Search results
Marea launches with $190m to develop cardiometabolic therapies
Pharmaceutical Technology via Yahoo Finance· 22 hours agoThird Rock Ventures spearheaded the Series A financing round while the Series ...rich lipoproteins,...
Ozempic, Wegovy, Mounjaro popularity soar as weight loss wonders
Pittsburgh Tribune-Review· 7 days agoFor Diane Lang, the big push to focus on her health and weight came from her grandchildren. Lang, of...
Can ADH help cure diabetes insipidus?
Medical News Today· 6 days agoDiabetes insipidus occurs when problems with antidiuretic hormone (ADH) cause the body to remove too much water. The condition that healthcare...
What Is the Maximum Dose of Ozempic for Weight Loss? Here's What You Need to Know
Parade via Yahoo News· 4 days agoFDA. FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. FDA. Dr....
Diabetes Not the Only Cause of Limb Loss
The Morning News· 5 days agoAn estimated 2.3 million people in the United States are living with limb loss, And the number is expected to rise to 3.5 million by 2050, according to...
Metformin slows colorectal cancer growth using microRNAs, study finds
MedicalNewsToday via AOL· 6 days agoA new cell study has shown the common type 2 diabetes medication metformin alters levels of...
New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye
Digital Journal· 2 days agoWith clinical colleagues, they have studied its dysregulation in diabetes and have patented treatments for treatment of dry eye and delayed ...
Ex-NBA player Nate Robinson says he needs to find a kidney donor soon as he battles life-threatening...
TODAY via Yahoo News· 11 hours agoOn days when he feels good after treatment, he trains at the gym and spends time with his children....
Potential new treatment option for diabetic retinopathy could address the problem much earlier
Medical Xpress· 2 days agoResearchers at the University of Oklahoma Health Sciences and Memorial Sloan Kettering (MSK) Cancer Center are studying a new, revolutionary treatment for diabetic retinopathy ...
Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 4 hours agoStockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Wednesday. The firm issued a sell rating on the biopharmaceutical company ...
